ImmunoACT
@actimmuno
Pioneers of India's first commercially available CAR-T cell therapy. - NexCAR19, powered by indigenously integrated genetic engineering for a healthier tomorrow
ID: 1404706950919561218
http://immunoact.com/ 15-06-2021 07:47:02
228 Tweet
1,1K Followers
36 Following
India’s first indigenous CAR-T therapy is now peer-reviewed in The Lancet Haematology , showing a 73% response rate—marking a breakthrough in accessible, cutting-edge cancer treatment.